Opioid Use Disorder Treatment and Potential Interactions With Novel COVID-19 Medications: A Clinical Perspective

Prim Care Companion CNS Disord. 2020 Jul 2;22(4):20com02703. doi: 10.4088/PCC.20com02703.
No abstract available

MeSH terms

  • Analgesics, Opioid / pharmacokinetics
  • Analgesics, Opioid / therapeutic use
  • Anti-Retroviral Agents / pharmacokinetics*
  • Betacoronavirus / drug effects
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / virology
  • Drug Interactions*
  • Humans
  • Opioid-Related Disorders / complications*
  • Opioid-Related Disorders / drug therapy*
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Analgesics, Opioid
  • Anti-Retroviral Agents